22EyesVision — Series A (estimated) · €950K
2EyesVision, a Madrid-region ophthalmic technology company behind the SimVis Gekko visual simulator, announced a €2 million funding round to accelerate growth and international expansion. Existing investors Bullnet Capital and Innvierte-CDTI had already committed €950,000 at announcement, and the company also secured a separate €300,000 ENISA Crecimiento loan; no venture stage was stated and no single lead was named.
Lead not disclosed
RoundSeries A (estimated)
Announced30 Apr 2025
CityMadrid · reported Tres Cantos
SectorHealthtech & Bio · Medtech / Ophthalmology
Source
P
E
C
P
E
C



